Almanac Health Raises $10 Million in Seed Funding for Clinical AI
Almanac Health has secured $10 million in a seed funding round to enhance its clinical AI platform aimed at supporting clinicians through research-validated decision-making tools. Founded by Dr. Cyril Zakka, the company received backing from notable investors including F-Prime, General Catalyst, and Lightspeed Venture Partners, with General Catalyst previously leading a pre-seed round.
BOSTON–(BUSINESS WIRE)–Almanac Health, a research-validated clinical AI platform and evidence-based clinical decision support company founded by physician-researcher Cyril Zakka, MD, whose work at Stanford introduced retrieval-augmented generation to clinical medicine, has raised $10 million in a seed round led by F-Prime, with participation from General Catalyst and Lightspeed Venture Partners. General Catalyst previously led the company’s pre-seed round with participation from Soma Capital.